hydroxyindoleacetic acid has been researched along with Ectopic Hormone Syndromes in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ectopic GHRH-secreting tumors, such as carcinoid, rarely cause acromegaly." | 1.30 | Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid. ( Drange, MR; Melmed, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drange, MR | 1 |
| Melmed, S | 1 |
1 other study available for hydroxyindoleacetic acid and Ectopic Hormone Syndromes
| Article | Year |
|---|---|
Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid.
Topics: Acromegaly; Adult; Antineoplastic Agents; Carcinoid Tumor; Growth Hormone-Releasing Hormone; Humans; | 1998 |